Characteristics of female lung cancer in Korea: analysis of Korean National Lung Cancer Registry.

Women lung cancer mortality pulmonary function smoking

Journal

Journal of thoracic disease
ISSN: 2072-1439
Titre abrégé: J Thorac Dis
Pays: China
ID NLM: 101533916

Informations de publication

Date de publication:
Sep 2020
Historique:
entrez: 4 11 2020
pubmed: 5 11 2020
medline: 5 11 2020
Statut: ppublish

Résumé

The present study evaluated Korean women with lung cancer and compared the clinical characteristics of ever-smoker and never-smoker groups using the National Lung Cancer Registry. In affiliation with the Korean Central Cancer Registry, the Korean Association for Lung Cancer constructed a registry into which 10% of the lung cancer cases in Korea were registered. Female lung cancer patients with valid smoking history were evaluated. Among 735 female lung cancer patients, 643 (87.5%) were never-smokers and 92 (12.5%) were smokers. The median survival was significantly longer in the never-smoker group (28 In Korean women with NSCLC, smoking status, not receiving active anticancer treatment, EGFR mutation status, lung cancer stage, and pulmonary function were significantly associated with mortality.

Sections du résumé

BACKGROUNDS BACKGROUND
The present study evaluated Korean women with lung cancer and compared the clinical characteristics of ever-smoker and never-smoker groups using the National Lung Cancer Registry.
METHODS METHODS
In affiliation with the Korean Central Cancer Registry, the Korean Association for Lung Cancer constructed a registry into which 10% of the lung cancer cases in Korea were registered. Female lung cancer patients with valid smoking history were evaluated.
RESULTS RESULTS
Among 735 female lung cancer patients, 643 (87.5%) were never-smokers and 92 (12.5%) were smokers. The median survival was significantly longer in the never-smoker group (28
CONCLUSIONS CONCLUSIONS
In Korean women with NSCLC, smoking status, not receiving active anticancer treatment, EGFR mutation status, lung cancer stage, and pulmonary function were significantly associated with mortality.

Identifiants

DOI: 10.21037/jtd-20-1671 PMID: 33145034 PMC: PMC7578488
pubmed: 33145034
doi: 10.21037/jtd-20-1671
pii: jtd-12-09-4612
pmc: PMC7578488
doi:

Types de publication

Journal Article

Langues

eng

Pagination

4612-4622

Informations de copyright

2020 Journal of Thoracic Disease. All rights reserved.

Déclaration de conflit d'intérêts

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/jtd-20-1671). The authors have no conflicts of interest to declare.

Références

Ann Oncol. 2013 Sep;24(9):2371-6
pubmed: 23723294
Thorac Cancer. 2019 Aug;10(8):1717-1724
pubmed: 31293059
Semin Oncol. 2009 Dec;36(6):506-15
pubmed: 19995642
J Thorac Oncol. 2014 Feb;9(2):154-62
pubmed: 24419411
J Thorac Oncol. 2014 Jun;9(6):812-7
pubmed: 24807154
J Thorac Oncol. 2013 Jul;8(7):923-9
pubmed: 23608817
Tuberc Respir Dis (Seoul). 2019 Apr;82(2):175-177
pubmed: 30915782
N Engl J Med. 2009 Sep 3;361(10):958-67
pubmed: 19692684
Thorax. 2012 May;67(5):426-32
pubmed: 22426791
Int J Chron Obstruct Pulmon Dis. 2019 May 01;14:929-938
pubmed: 31118602
Cancer Invest. 2017 May 28;35(5):358-365
pubmed: 28350480
CA Cancer J Clin. 2015 Mar;65(2):87-108
pubmed: 25651787
Chin J Cancer. 2017 Feb 8;36(1):20
pubmed: 28179026
PLoS One. 2019 Jul 1;14(7):e0219080
pubmed: 31260495
J Clin Oncol. 2005 Apr 10;23(11):2513-20
pubmed: 15738541
Lung Cancer. 2016 Jun;96:63-7
pubmed: 27133752
J Thorac Oncol. 2011 Feb;6(2):305-9
pubmed: 21150675
Br J Cancer. 2014 Jan 7;110(1):12-8
pubmed: 24178761
CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108
pubmed: 15761078
Lung Cancer. 2019 Mar;129:8-15
pubmed: 30797496
Semin Thorac Cardiovasc Surg. 2013 Summer;25(2):87-94
pubmed: 24216523
AJR Am J Roentgenol. 2011 Feb;196(2):287-95
pubmed: 21257878
Am J Epidemiol. 2013 Apr 1;177(7):613-6
pubmed: 23425628
Cancer Res Treat. 2019 Oct;51(4):1400-1410
pubmed: 30913875
Eur J Cancer. 2013 Apr;49(6):1374-403
pubmed: 23485231
Lung Cancer. 2019 Mar;129:1-7
pubmed: 30797485
J Natl Cancer Inst. 2005 Mar 2;97(5):339-46
pubmed: 15741570
Respir Med. 2012 Sep;106(9):1301-8
pubmed: 22749756
Eur Respir J. 2008 Feb;31(2):391-5
pubmed: 17928313
Lung Cancer. 2005 Apr;48(1):1-9
pubmed: 15777966
Korean J Intern Med. 2011 Dec;26(4):427-31
pubmed: 22205843

Auteurs

Jeong Uk Lim (JU)

Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Solji Han (S)

Department of Applied Statistics, Yonsei University, Seoul, Korea.

Ho Cheol Kim (HC)

Department of Pulmonary and Critical Care Medicine, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Korea.

Chang Min Choi (CM)

Department of Pulmonary and Critical Care Medicine, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Korea.

Chi Young Jung (CY)

Department of Internal Medicine, Daegu Catholic University School of Medicine, Daegu, Korea.

Deog Gon Cho (DG)

Department of Thoracic & Cardiovascular Surgery, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Suwon, Korea.

Jae Hyun Jeon (JH)

Department of Thoracic and Cardiovascular Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seoul, Korea.

Jeong Eun Lee (JE)

Division of Pulmonology Department of Internal Medicine, Chungnam National University, Daejeon, Korea.

Jin Seok Ahn (JS)

Department of Medicine, Samsung Medical Center, Sungkyunkwan University, Seoul, Korea.

Yeongdae Kim (Y)

Department of Cardiothoracic Surgery, Pusan National University Hospital, Pusan, Korea.

Yoo-Duk Choi (YD)

Department of Pathology, Chonnam National University, Hwasun Hospital, Hwasun, Korea.

Yang-Gun Suh (YG)

Proton Therapy Center, Research Institute and Hospital, National Cancer Center, Goyang, Korea.

Jung-Eun Kim (JE)

Cancer Registration and Statistics Branch, National Cancer Center, Goyang, Korea.

Young-Joo Won (YJ)

Cancer Registration and Statistics Branch, National Cancer Center, Goyang, Korea.

Young-Chul Kim (YC)

Department of Internal Medicine, Chonnam National University, Hwasun Hospital, Hwasun, Korea.

Chan Kwon Park (CK)

Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Seung Joon Kim (SJ)

Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Postech-Catholic Biomedical Engineering Institute, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Classifications MeSH